Key Insights: Real-World Evidence for ITP Treatment

Key Insights: Real-World Evidence for ITP Treatment

imedex

7 months
139 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Earn CME Credit: https://www.naccme.com/program/7327 Knowledge is evolving regarding numerous clinical aspects of immune thrombocytopenic purpura (ITP), and there remains significant variability in clinical practice patterns for its management. This activity features Drs. David P. Steensma and Ilene C. Weitz sharing their insights about data recently released in publication form pertaining to pharmacotherapy for ITP, with a focus on the use of thrombopoietin (TPO) receptor agonists. © 2019 Imedex, an HMP Company
Up Next Autoplay
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Category: Liver Cancer
3 Views
imedex 5 days
CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity
CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity
Category: Lymphoma
1,009 Views
imedex 4 months
Update: Relapsed/Refractory Follicular Lymphoma
Update: Relapsed/Refractory Follicular Lymphoma
Category: Lymphoma
387 Views
imedex 4 months
Follicular Lymphoma: Update on Upfront and Maintenance Therapy
Follicular Lymphoma: Update on Upfront and Maintenance Therapy
Category: Lymphoma
324 Views
imedex 4 months
CAR-T in Lymphoma
CAR-T in Lymphoma
Category: Lymphoma
240 Views
imedex 4 months
Peripheral T-Cell Lymphoma: What is New on the Horizon?
Peripheral T-Cell Lymphoma: What is New on the Horizon?
Category: Lymphoma
226 Views
imedex 4 months
AML Case: A 54-year-old woman is in remission but MRD+
AML Case: A 54-year-old woman is in remission but MRD+
Category: Acute Myelogenous Leukemia
114 Views
imedex 5 months
Update: New Drugs for AML
Update: New Drugs for AML
Category: Acute Myelogenous Leukemia
175 Views
imedex 5 months
R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics
R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics
Category: Chronic Lymphocytic Leukemia
163 Views
imedex 5 months
CLL: Sequencing Monotherapy vs. Combination Therapy
CLL: Sequencing Monotherapy vs. Combination Therapy
Category: Chronic Lymphocytic Leukemia
87 Views
imedex 5 months